Literature DB >> 18930092

Lysophosphatidylcholine induces delayed myelination in the juvenile ventral hippocampus and behavioral alterations in adulthood.

Manabu Makinodan1, Kouko Tatsumi, Hiroaki Okuda, Takayuki Manabe, Takahira Yamauchi, Yoshinobu Noriyama, Toshifumi Kishimoto, Akio Wanaka.   

Abstract

Maternal virus infection or maternal polyinosinic-polycytidilic acid injection confers behavioral alterations including deficit in prepulse inhibition on the offspring. We previously found delayed myelination specifically in the early postnatal hippocampus in the polyinosinic-polycytidilic acid-injection model. To test whether the transient delay in myelination in the juvenile hippocampus leads to abnormal behaviors after adolescence, we injected lysophosphatidylcholine, a potent demyelinating agent, into the ventral hippocampus of the 10-day-old rat. The lysophosphatidylcholine treatment yielded hypomyelination at postnatal day 16, but myelination reverted to normal level in the adult rat. Neuronal arrays and morphology were not disturbed in this model. We then performed a battery of behavioral tests on the lysophosphatidylcholine-treated and control PBS-injected rats. The lysophosphatidylcholine-treated rats showed deficit in prepulse inhibition, motor hyperactivity in response to methamphetamine and anxiety-related behaviors, all of which are typical behaviors observed in the maternal infection models. These findings suggest that the timing of myelination in the early postnatal hippocampus is crucial for the proper development of sensorimotor and emotional functions. The lysophosphatidylcholine-treated rat without a gross anatomical defect is useful as a model for psychotic disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930092     DOI: 10.1016/j.neuint.2008.09.009

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  The neurobiology of transition to psychosis: clearing the cache.

Authors:  Lena Palaniyappan; Tushar Das; Kara Dempster
Journal:  J Psychiatry Neurosci       Date:  2017-09       Impact factor: 6.186

Review 2.  Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.

Authors:  Nagahide Takahashi; Takeshi Sakurai; Kenneth L Davis; Joseph D Buxbaum
Journal:  Prog Neurobiol       Date:  2010-10-13       Impact factor: 11.685

3.  Loss of Hippocampal Oligodendrocytes Contributes to the Deficit of Contextual Fear Learning in Adult Rats Experiencing Early Bisphenol A Exposure.

Authors:  Xiao-Bin Xu; Shi-Jun Fan; Ye He; Xin Ke; Chen Song; Yao Xiao; Wen-Hua Zhang; Jun-Yu Zhang; Xiao-Ping Yin; Nobumasa Kato; Bing-Xing Pan
Journal:  Mol Neurobiol       Date:  2016-06-30       Impact factor: 5.590

4.  Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.

Authors:  Kevin R Krull; Marilyn J Hockenberry; Petra Miketova; Marissa Carey; Ida M Moore
Journal:  Leuk Lymphoma       Date:  2012-08-30

5.  Decrease in Myelin-Associated Lipids Precedes Neuronal Loss and Glial Activation in the CNS of the Sandhoff Mouse as Determined by Metabolomics.

Authors:  Emmanuelle Lecommandeur; Maria Begoña Cachón-González; Susannah Boddie; Ben D McNally; Andrew W Nicholls; Timothy M Cox; Julian L Griffin
Journal:  Metabolites       Date:  2020-12-30

Review 6.  A putative functional role for oligodendrocytes in mood regulation.

Authors:  N Edgar; E Sibille
Journal:  Transl Psychiatry       Date:  2012-05-01       Impact factor: 6.222

7.  Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.

Authors:  Sepideh Tarbali; Shiva Khezri
Journal:  Iran J Basic Med Sci       Date:  2016-01       Impact factor: 2.699

8.  Metabolomic and transcriptomic signatures of prenatal excessive methionine support nature rather than nurture in schizophrenia pathogenesis.

Authors:  Siwei Chen; Wedad Alhassen; Ryan Yoshimura; Angele De Silva; Geoffrey W Abbott; Pierre Baldi; Amal Alachkar
Journal:  Commun Biol       Date:  2020-07-30

9.  Transcriptomic, proteomic, and metabolomic analyses identify candidate pathways linking maternal cadmium exposure to altered neurodevelopment and behavior.

Authors:  Kathleen M Hudson; Emily Shiver; Jianshi Yu; Sanya Mehta; Dereje D Jima; Maureen A Kane; Heather B Patisaul; Michael Cowley
Journal:  Sci Rep       Date:  2021-08-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.